Matthew R Sinclair
Overview
Explore the profile of Matthew R Sinclair including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sinclair M, Ardehali M, Diamantidis C, Corsino L
Front Public Health
. 2024 Nov;
12:1412874.
PMID: 39525461
Type 2 diabetes (T2D) affects millions of individuals worldwide and is a well-documented risk factor for cardiovascular (CV) disease and chronic kidney disease, both of which are leading causes of...
2.
Eichenberger E, Ruffin F, Sharma-Kuinkel B, Dagher M, Park L, Kohler C, et al.
Transpl Infect Dis
. 2021 Sep;
23(6):e13730.
PMID: 34500502
Introduction: Outcomes from Staphylococcus aureus bacteremia (SAB) in solid organ transplant (SOT) recipients are poorly understood. Methods: This is a prospective cohort study comparing the bacterial genotype and clinical outcomes...
3.
Sinclair M, Souli M, Ruffin F, Park L, Dagher M, Eichenberger E, et al.
Am J Kidney Dis
. 2021 Jul;
79(3):393-403.e1.
PMID: 34303771
Rationale & Objective: Staphylococcus aureus (Saureus) bacteremia (SAB) is associated with morbidity and mortality in patients receiving maintenance hemodialysis (HD). We evaluated changes in clinical and bacterial characteristics, and their...
4.
Eichenberger E, Dagher M, Sinclair M, Maskarinec S, Fowler Jr V, Federspiel J
Am Heart J
. 2021 Jun;
240:63-72.
PMID: 34157299
Background: The epidemiology, and outcome of infective endocarditis (IE) among solid organ transplant (SOT) recipients is unknown. Methods: We used data from the 2013-2018 Nationwide Readmissions Database (NRD). IE- and...
5.
Cohen J, South A, Shaltout H, Sinclair M, Sparks M
Clin Kidney J
. 2021 Apr;
14(Suppl 1):i48-i59.
PMID: 33796285
In the early months of the coronavirus disease 2019 (COVID-19) pandemic, a hypothesis emerged suggesting that pharmacologic inhibitors of the renin-angiotensin system (RAS) may increase COVID-19 severity. This hypothesis was...